Identification of A-to-I RNA editing profiles and their clinical relevance in lung adenocarcinoma.
- Published in:
- SCIENCE CHINA Life Sciences, 2022, v. 65, n. 1, p. 19, doi. 10.1007/s11427-020-1928-0
- By:
- Publication type:
- Article
Works by Gong, Linnan
Results: 6
1
2
The association between METS-IR, an indirect index for insulin resistance, and lung cancer risk.
- Published in:
- European Journal of Public Health, 2024, v. 34, n. 4, p. 800, doi. 10.1093/eurpub/ckad234
- By:
- Publication type:
- Article
3
Development and validation of a lung cancer polygenic risk score incorporating susceptibility variants for risk factors.
- Published in:
- International Journal of Cancer, 2025, v. 156, n. 5, p. 953, doi. 10.1002/ijc.35210
- By:
- Publication type:
- Article
4
Family history and genetic risk score combined to guide cancer risk stratification: A prospective cohort study.
- Published in:
- International Journal of Cancer, 2025, v. 156, n. 3, p. 505, doi. 10.1002/ijc.35187
- By:
- Publication type:
- Article
5
Integrative analyses of N6‐methyladenosine‐associated single‐nucleotide polymorphisms (m6A‐SNPs) identify tumor suppressor gene AK9 in lung cancer.
- Published in:
- Molecular Carcinogenesis, 2024, v. 63, n. 3, p. 538, doi. 10.1002/mc.23669
- By:
- Publication type:
- Article
6
Functional characterization and clinical significance of super‐enhancers in lung adenocarcinoma.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 8, p. 776, doi. 10.1002/mc.23419
- By:
- Publication type:
- Article